Conforms to：CP/EP/USP

Material name：Furosemide

CAS NO.：54-31-9

Formula：C₁₂H₁₁ClN₂O₅S

Structure：

Appearance: White to light yellowish powder

Packaging System:

• Primary: Two-ply LDPE bags

• Secondary:  Fiberboard drum

• Net content: 20 kilograms per drum

Primary use: Mainly used to treat edematous conditions, hypertension, and heart failure by increasing urine output, reducing blood pressure, and decreasing cardiac workload. Clinically indicated for: Edematous disorders, Renal diseases, Hypertension, Hyperkalemia and hypercalcemia, Dilutional hyponatremia, Syndrome of inappropriate antidiuretic hormone secretion (SIADH), Acute tubular necrosis.

Therapeutic Applications: Widely used in clinical management of cardiovascular and renal diseases, demonstrating high safety and efficacy.

Regulatory Status: Production license obtained, Process validation batch production completed. Expected to receive marketing authorization approval in 2026. Process validation batch products available in stock.